Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.5.0.2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 24, 2016
Jan. 01, 2016
Oct. 21, 2015
Dec. 20, 2013
Aug. 31, 2016
Aug. 31, 2015
Aug. 31, 2016
Aug. 31, 2015
Mr. Andrew I. Sealfon [Member] | Lease Agreement [Member] | Aircraft [Member]                
Lease payments         $ 5,375 $ 5,375 $ 10,750 $ 10,750
Mr. Mark Pastreich [Member] | Lease Agreement [Member] | Building [Member]                
Description of lease terms            

Seventeen of a twenty-year lease.

 
Mr. Mark Pastreich [Member] | Lease Agreement [Member] | Building [Member]                
Lease payments         33,126 33,126 $ 66,252 66,252
Clinical Research & Support Services Consulting Agreement [Member] | Dr. Paul Mark Baker [Member]                
Amortization of deferred compensation cost         7,000 $ 7,000 14,000 $ 14,000
Clinical Research & Support Services Consulting Agreement [Member] | FREEDOM60 Syringe Infusion System [Member] | Dr. Paul Mark Baker [Member]                
Number of shares issued upon agreement       420,000        
Share price (in dollars per share)       $ 0.20        
Agreement term       3 years        
Consulting Agreement [Member] | Mr. Cyril Narishkin [Member]                
Monthly payment for agreement   $ 16,000 $ 16,000          
Description of payment terms  

Seventy-five percent was to be paid in cash and twenty-five percent was to be paid in shares of common stock.

Half was to be paid in cash and half was to be paid in shares of common stock.

         
Consulting Agreement [Member] | Mr. Cyril Narishkin (Consultant) [Member]                
Monthly payment for agreement $ 16,000              
Officer compensation         $ 48,000   $ 150,000  
Number of shares repurchased             96,542  
Value of shares repurchased             $ 43,393